Abstract: Provided is a diagnosis method for an autoimmune disease, including a step of measuring the relative abundances of bacteria included in a fecal sample collected from a test subject; and a step of performing the following (1), for example: (1) in a case in which relative abundance of a bacterium whose nucleotide sequence of 16S ribosomal RNA gene has an identity of 99% or higher with nucleotide sequence set forth in SEQ ID NO:3 or SEQ ID NO:4, is large compared to the relative abundance in healthy subject, determining that the test subject has contracted, or has a high risk of contracting, the autoimmune disease.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: The present invention provides a composition for preventing or treating a graft-versus-host disease, the composition comprising a fecal microbiota.

Abstract: An ECU (Electronic Control Unit) evaluation apparatus, for use in vehicle design, allocates functions appropriately to respective ECUs of a vehicle. The function allocation can be performed based on user-specified priority aspect(s) in conjunction with stored information concerning the respective functions and information concerning the ECUs, such as installation positions on the vehicle, mechanical and electrical specifications of component parts of ECUs, etc.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: Strains of human-derived bacteria have been obtained from complex fecal samples and shown to induce accumulation of Th17 cells in the intestine and promote immune functions. Pharmaceutical compositions containing these bacteria can be used as anti-infectives and as adjuvants in mucosal vaccines.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: A vehicle-mounted network system includes a plurality of electronic control units (ECUs) communicatively connected to a communication path of a vehicle-mounted network, each of which is configured to selectively perform a normal mode of operation and a sleep mode, and a management apparatus. The plurality of ECUs are configured to be individually powered on and off by a power supply relay of the management apparatus. The management apparatus is configured to acquire information indicative of a vehicle situation and determine a scene from the acquired information, determine control contents for powering on or off at least one specific ECU, of the plurality of ECUs, corresponding to the determined scene, if any, and power on or off the at least one specific ECU based on the determined control contents.

Abstract: A vehicle-mounted network system includes a plurality of electronic control units (ECUs) communicatively connected to a communication path of a vehicle-mounted network, each of which is configured to selectively perform a normal mode of operation and a sleep mode, and a management apparatus. The plurality of ECUs are configured to be individually powered on and off by a power supply relay of the management apparatus. The management apparatus is configured to acquire information indicative of a vehicle situation and determine a scene from the acquired information, determine control contents for powering on or off at least one specific ECU, of the plurality of ECUs, corresponding to the determined scene, if any, and power on or off the at least one specific ECU based on the determined control contents.

Abstract: A wiring harness evaluation apparatus includes a functional allocation means which allocates functions realized by a plurality of ECUs installed in a vehicle to the ECUs, a routing path setting means which sets a routing path of a wiring harness in conformity with the allocation by the functional allocation means, a component selection means which selects components for configuring the wiring harness in conformity with the routing path set by the routing path setting means, and an evaluation value calculation means which calculates an evaluation value for at least one of a total weight of the components, total cost of the components, and total length of electric wires configuring the wiring harness on the basis of information on the components selected by the component selection means.

Abstract: An ECU (Electronic Control Unit) evaluation apparatus, for use in vehicle design, allocates functions appropriately to respective ECUs of a vehicle. The function allocation can be performed based on user-specified priority aspect(s) in conjunction with stored information concerning the respective functions and information concerning the ECUs, such as installation positions on the vehicle, mechanical and electrical specifications of component parts of ECUs, etc.

Abstract: Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Abstract: An accelerating agent for elimination of dioxins which comprises, as an active ingredient, a microorganism having an activity of accelerating elimination of dioxins in the body to the outside of the body.

Abstract: An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species Lactobacillus reuteri and is capable of producing lipases having the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5 or amino acid sequences having deletion, substitution or addition of one or more amino acids in the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5. The anti-obesity agent enables a patient to take a normal meal yet preventing the absorption of a fat into the body which is the primary cause of obesity.

Abstract: An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species Lactobacillus reuteri and is capable of producing lipases having the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5 or amino acid sequences having deletion, substitution or addition of one or more amino acids in the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5. The anti-obesity agent enables a patient to take a normal meal yet preventing the absorption of a fat into the body which is the primary cause of obesity.